We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Filters

Equity Crowdfunding Pitches

Showing results
vFloorplan creates innovative, interactive Meeting and 3D event floorplans making it easy for potential customers and booking agents to explore venue layouts. The Kia Oval, QEII Centre and National Conference Centre (National Motorcycle Museum) are a few customers already using vFloorplan 3D, with recurring revenue and great feedback. Till now, the company has achieved a waiting list of 100+ venues, contractual relationships with 3 major partners and they are also the finalists in the National Entrepreneur Awards. They are seeking funding for a rollout to almost 200 UK venues including key Premiership Football Clubs, major UK tourist attractions and notable hotel brands.

Pitch Rated

80%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £54,700
ZoomEV is a company that aims to be a 'Mobility as a Service' (MaaS) provider by combining the Electric Vehicle (EV) and Vehicle Sharing (VS) markets to combat climate change. The company provides services such as EV sharing, EV insurance and EV Driver Benefits Bundle. EVs will account for 57% of new car sales by 2040 and the UK sharing economy would see a 20 fold increase to £140 billion by 2025. ZoomEV aims to be a strong contender in this segment. The company has partnered with organisations such as BP Chargemaster, EO Charging, SSE, and Q-Park. It also has global franchised motorcar dealership Jardine Motors Group to boost its growth. Zoom will use the investment to scale its business by accelerating marketing activity in core areas, employ sales personnel to target the EV sales/leasing sector and build its app.

Pitch Rated

80%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £278,678
Auddy is on a mission to build a data-driven podcast publisher for mainstream audio podcasts from top producers. The company points out that 1 in 5 people listen to podcasts in the UK, with over 50 million episodes published each day. Auddy stresses that this creates significant competition and confusion for the podcast producers, with many great podcasts going unnoticed due to a lack of editorial, promotional, and commercial support. Auddy intends to change this. The company guides a creator’s show from birth to distribution and advertising sales, helping creators make money via royalty shares. Auddy claims to use data to research shows that need to be broadcast. It fine-tunes the show for editorial and commercial advantage. Auddy points out that its podcast catalogue witnessed 5.5 million UK downloads. It wants to become a contender in the £7 billion podcast industry and has featured in press such as the Telegraph, Financial Times and The Guardian. The company states it will use the investment to become a data-centric publisher for its producers and customers alike globally.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £681,371
Avida Global (AG) is a Business-to-Business (B2B) producer of high-quality medicinal cannabis oils and derivatives for the global medical, well-being and cosmeceutical markets. The company has a cultivation and processing facility in North-East Colombia. It asserts that the therapeutic properties of the cannabis plant has driven 53 countries to legalise its use, with more to follow. AG seeks to capture this demand and become a contender in the medicinal cannabis market that is expected to soar from $33.1 billion to $84.0 billion by 2028. The company has received regulatory approvals for initial non-psychoactive cannabis cultivation, manufacturing, and export licences in 2019. It is working on a partnership with a medicinal cannabis prescriber through doctors and clinics for the supply of medicinal cannabis strains in the UK. The company will use 40% of the investment to drive revenue growth, 25% as capital expenses, and 35% as additional operating expenses.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,646,249
HaMuch is an online platform that lets homeowners compare hourly rates of local tradespeople and check their availability. The company has provided digital marketing services to businesses such as Travis Perkins, HomeServe, and Rated People. About 200,000 tradespeople have uploaded their profiles on the platform with 12,000+ having uploaded their respective prices. The company has been featured in The Sunday Telegraph, Express, Sun, and Microsoft News. 

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £132,850
Hoptroff TTaaS® software is a hassle-free compliance solution for financial services under MIFID II and CAT regulations. Traceable Time as a Service (TTaaS®) ensures that timestamp records of computer transactions are accurate to the microsecond, making online transactions trustworthy, reducing fraud, regulatory risk and the cost of business for Financial Services and Media. Hoptroff is building their presence in the US – the largest potential market worth $30bn. They are fundraising with the goals to invest in PoC trials for the growing pipeline of potential global customers introduced by their partners, transitioning from annual up-front fees to monthly payments with BTR and invest in launching IP Media service.

Pitch Rated

79%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £865,000
Imagen is a company that has developed an automated, sophisticated algorithmic technique, PredictRx, to find the right treatment for any cancer type. Imagen collects the cancer samples from a patient, grows it in its specialised growth medium, and then subjects the medium to an automated fluorescence microscopy screening to measure drug responses on live tumour cells. The company's AI-powered biobank of over 150,000 drug responses then gives the best possible cancer treatment options, allowing the company to expand in the pharmaceutical sector by satisfying its unmet demand for patient-derived cancer models. Imgen requires investment to scale its infrastructure to create the world's leading 'Biobank' of clinically relevant patient-derived cancer models whilst building the most comprehensive big data set available in cancer research.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,036,436
Service Robotics Ltd is a unique service designed to help older adults live independently in their own homes. This game-changing service offers voice-enabled face-to-face human support through an adorable intelligent Genie robot. The company's roadmap includes IT integration to turn the home into a cocoon of wellness, health, and companionship. The company has been actively piloting the GenieConnect® platform solution since 2018. Service Robotics Ltd won its first contract in November 2019 from the NHS/SBRI programme. GenieConnect® has agreed on pilot projects with 3 care and retirement organisations, applied for an Innovate UK grant in March.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £569,430
SleepCogni combines a handheld device and a Software as a Service (SaaS) platform to help users wind down by collecting physiological, behavioural and environmental data. The company points out that 1 million people in the UK take sleeping pills for insomnia. SleepCogni intends to change this with its product. It claims that its device receives data from fifteen different sensors, providing detailed insights into a user’s sleep struggle to further assist in clinical intervention, including procedures such as CBT-I (Cognitive Behavioural Therapy for Insomnia). The company's initial target sleep clinics are the UK and the US, with the US sleep clinic market estimated to be worth $9 billion in 2020. SleepCogni has eleven granted and four pending patents in various territories, a trademark on the logo and protection of specific handheld trigger hardware. They state they will use the investment received to commercialise their product.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £577,270
Alphagreen is Europe's largest online marketplace for Cannabidiol (CBD) healthcare products listing over 150 brands and more than 2,500 products on its portal. It claims that it is backed by high-profile cannabis investors like Enexis, West Creek Investments, and others. It aspires to become the leader in the CBD market that is expected to be worth over £900 million in 2025 in the UK alone. Alphagreen aspires to build a trusted ecosystem for customers with Sleep, Pain and Anxiety problems, enable them to access alternative healthcare, and distribute medical cannabis from Q3 of 2021. The company has featured in Forbes, Business Insider, Prohibition Partners, The Financial Times, and The Grocer. It will use 31% of the investment for sales and marketing, 25% for team expansion, 16% for general corporate affairs, 15% for international expansion, and 13% for technology up-gradation.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £2,039,375
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph